First Patient Treated in CLINUVEL DNA Repair Study
Melbourne, Australia, 22 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreCLINUVEL Investor webinar
CLINUVEL PHARMACEUTICALS LTD today announced an Investor Webinar shall be held on...
Read MoreAppendix 4G & Corporate Governance Statement
Melbourne, Australia, 08 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreCLINUVEL PHARMACEUTICALS LTD 2021 Annual General Meeting - Notice of Meeting & Explanatory Memorandum
Melbourne, Australia, 08 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreOperations Update II
Melbourne, Australia, 07 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreOperations Update Webcast II
Melbourne, Australia, 07 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreCLINUVEL Progresses DNA Repair Program
Melbourne, Australia, 05 October 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreCLINUVEL Key Events and Announcements
Melbourne, Australia, 23 September 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreCLINUVEL Confirms AGM Date
Melbourne, Australia, 22 September 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MorePresentation H.C. Wainwright Global Investment Conference
Melbourne, Australia, 14 September 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreCLINUVEL Kommuniqué IV
Sehr geehrte Aktionärinnen und Aktionäre, liebe Freunde, Einleitung Zufrieden blicken wir auf...
Read MoreCLINUVEL Investor Webinar Financial Results Year Ended 30 June 2021
Melbourne, Australia, 27 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreCLINUVEL Communiqué IV
Dear Shareholders, Friends Introduction With satisfaction, we look back at an eventful...
Read MoreCorporate Presentation - FY2021 Results
Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreAppendix 4E and Preliminary Financial Report
Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read More